The effect of 12-month enzyme replacement therapy on myocardial perfusion in patients with Fabry disease.
Kalliokoski RJ, Kantola I, Kalliokoski KK, Engblom E, Sundell J, Hannukainen JC, Janatuinen T, Raitakari OT, Knuuti J, Penttinen M, Viikari J, Nuutila P.
J Inherit Metab Dis. 2006 Feb;29(1):112-8.PMID: 16601877 [PubMed - indexed for MEDLINE]Related articles